Erratum

Article Outline

• Copyright

In the October, 2011 issue, errors were discovered in Table 1 in the article “Radiation Therapy for Liver Metastases” [Semin Radiat Oncol 21(4):264-270] by Tracey E. Schefter, MD, and Brian D. Kavanagh, MD. The table appears on page 268 of the issue. Please see corrected table below.

Table 1. SBRT for Liver Metastases: Outcomes

	Patients	Lesions	SBRT (PTV dose)	PTV	Time Point	Local Control	Comments
Heidelberg, 200448⁎	37	60	11-21 Gy × 1	GTV + 6 mm axial + 10 mm sup-inf	18mo	<16 Gy: 0% >16 Gy: 81%
Wuerzburg, 200649	39	51	7 Gy × 4 10 Gy × 3 12.5 Gy × 3 26 Gy × 1	GTV + 8 mm axial + 13 mm sup-inf	2y	28-30 Gy: 58% >30 Gy: 82% P < 0.01
Aarhus, Copenhagen, 200650⁎	44	Not stated	10 Gy × 3	GTV + 5 mm axial + 10 mm sup-inf	2y	79%	3 ulcer, intestinal dose >30 Gy
Erasmus U, Rotterdam, 201051	20	31	12.5 Gy × 3 (18 pts) 15 Gy × 3 (2 pts)	Individualized	2y	74%	1 late portal HTN in multiply treated patient
Colorado/multi-institutional, 200930⁎	47	63	12-20 Gy × 3	GTV + 5 mm axial + 10 mm sup-inf	2y	≤3 cm: 100% >3 cm: 77% P = 0.015
PMH, 200931⁎	68	141	Variable, NTCP-based Median 7 Gy × 6	Individualized (5 mm minimum)	1y	71%	Dose response for LC
Stanford, 201046⁎	19	33	18-30 Gy × 1	ITV + 3-5 mm or GTV + 5-10 mm without 4D-CT	1y	77%
University of Texas Southwestern Medical Center, 201032⁎	26	35	6 Gy × 5	ITV + 5 mm	2y	30 Gy: 56%
			10 Gy × 5			50 Gy: 89%
			12 Gy × 5			60 Gy: 100%

Abbrevations: PTV, planning target volume; ITV, internal target volume; LC, local control; MTD, maximum tolerated dose; PMH, Princess Margaret Hospital; 4D, 4-dimensional; pts, patients; sup-inf, superior and inferior.